New Zealand markets closed

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.07-0.07 (-1.36%)
At close: 04:00PM EDT
5.06 -0.01 (-0.20%)
After hours: 04:06PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.87-0.91-3.69-3.34
Low estimate-1.2-1.21-4.77-4.94
High estimate-0.69-0.69-2.8-1.05
Year ago EPS-0.85-1.3-5.81-3.69
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate720k720k2.8M32.08M
Low estimateN/AN/AN/AN/A
High estimate1.8M1.8M7M130.4M
Year ago sales2.95MN/A9.94M2.8M
Sales growth (year/est)-75.60%N/A-71.80%1,045.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.09-1.13-1.14-1.14
Actual EPS-0.85-1.3-1.43-2.18
Difference0.24-0.17-0.29-1.04
Surprise %22.00%-15.00%-25.40%-91.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.87-0.91-3.69-3.34
7 days ago-0.87-0.91-3.69-3.34
30 days ago-0.95-1.05-4.11-3.08
60 days ago-0.95-1.05-4.11-3.08
90 days ago-0.95-1.05-4.11-3.08
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days3332
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSYRSIndustrySector(s)S&P 500
Current qtr.-2.40%N/AN/AN/A
Next qtr.30.00%N/AN/AN/A
Current year36.50%N/AN/AN/A
Next year9.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A